Results of the October 2011 Innovation grants competition

Grants and awards

Our partnerships

Performance and accountability

Funding results

Research portfolio

Policies and administration

Access the CCSRI
online grant management
system

EGrAMS

Results of the October 2011 Innovation grants competition

We are pleased to announce the results of the inaugural Innovation grants competition to support unique and creative research ideas that will impact cancer. Below is a listing of newly awarded Canadian Cancer Society (CCS) Innovation grants.

Out of a total of 121 grant applications, 23 Canadian Cancer Society Innovation grants have been approved. All grants have been awarded to a maximum budget of $200,000 within a maximum 3 year term. The 23 grants that are being offered in this competition amount to over $4.5 million in funding over the terms of these grants. This is greater than the 15-20 grants originally budgeted for this competition as a result of additional funds allocated to research from the Society’s divisions; this was made possible by the significant efforts of our volunteers and donors across the country. We are also very pleased that all grants are being funded to their full panel recommended amounts and that no administrative decrements are being applied.

Competition statistics

Summaries of awarded grants

Please note:

Amounts listed below represent the total dollars awarded by grant year and may include funds for salaries, supplies, and/or equipment.
The start date for these grants is February 1, 2012.
Only the Principal Investigator is named in this listing. Co-Principal Investigators, Co-Applicants and/or Additional Authors may also be associated with these grants.

Note Carefully:

Although every effort has been made to ensure the accuracy of the listing below, this list does not constitute an "official" notification.

Successful applicants will be informed, in writing, with an official Notification of Award giving the details pertaining to their grant.

Applicant Institution Title	Award
Auer, Rebecca Ottawa Hospital Research Institute Oncolytic viruses for perioperative targeting of natural killer cells in cancer	2012/2013 : $99,733 2013/2014 : $99,733
Collins, Colin University of British Columbia Computational discovery of biomarkers targets in prostate cancer	2012/2013 : $91,960 2013/2014 : $91,960
Coomber, Brenda University of Guelph Predicting and improving responses of colorectal cancer patients to anti-VEGF therapy: TGF-beta modulation of endothelial VEGFR2 expression	2012/2013 : $99,197 2013/2014 : $99,101
Ehrhardt, Goetz University of Toronto Biomarker discovery in multiple myeloma: novel applications for ancient antibodies	2012/2013 : $99,645 2013/2014 : $99,645
Helgason, Cheryl BC Cancer Agency (Vancouver) Long non-coding RNA in prostate cancer	2012/2013 : $71,670 2013/2014 : $64,165 2014/2015 : $64,165
Hieter, Philip University of British Columbia Synthetic cytotoxicity in genetic model systems to identify potential anti-cancer therapeutic regimes	2012/2013 : $99,600 2013/2014 : $99,600
Husain, Amna Mount Sinai Hospital Online communication application for collaborative patient care in cancer	2012/2013 : $100,000 2013/2014 : $97,750
Kane, Kevin University of Alberta Prostate cancer T cell immunomics: CTL array	2012/2013 : $99,991 2013/2014 : $99,991
Korbelik, Mladen BC Cancer Agency (Vancouver) Photodynamic therapy treatment as a tool for generating cancer vaccines	2012/2013 : $99,995 2013/2014 : $99,995
Liu, Fei-Fei Ontario Cancer Institute/PMH The blood-brain-bone (3B) triad of radiation-induced fatigue	2012/2013 : $99,160 2013/2014 : $99,160
Loewen, Christopher University of British Columbia Small molecule antagonists of intracellular acid stress in cancer	2012/2013 : $100,000 2013/2014 : $100,000
Minchinton, Andrew BC Cancer Agency (Vancouver) Using pharmacological GSK-3 inhibitors to target contact-derived drug-resistance in cancer	2012/2013 : $99,756 2013/2014 : $99,756
Murphy, Leigh University of Manitoba Epigenetic-like codes for estrogen receptor alpha (ERa): ERa phosphorylation profiling ex vivo in human breast tumours	2012/2013 : $100,000 2013/2014 : $98,150
Penn, Linda Ontario Cancer Institute/PMH A novel strategy to identify small-molecules regulating the Myc oncoprotein	2012/2013 : $91,225 2013/2014 : $91,225
Pickering, J Geoffrey University of Western Ontario Stabilization of tumour vessels	2012/2013 : $66,580 2013/2014 : $66,580 2014/2015 : $66,580
Rak, Janusz The Research Institute of the McGill University Health Centre (RI-MUHC) Age-specific antiangiogenic therapy	2012/2013 : $100,000 2013/2014 : $100,000
Rosin, Miriam BC Cancer Research Centre HPV in tonsils: natural history of infection and role in oral cancers	2012/2013 : $73,225 2013/2014 : $79,550 2014/2015 : $47,225
Saleh, Maya McGill University Host genetic determinants of colon cancer metastasis	2012/2013 : $100,000 2013/2014 : $99,376
Shah, Sohrab BC Cancer Agency (Vancouver) Finding driver mutations in cancer through integrative profiling of mutational landscapes and transcriptional networks	2012/2013 : $99,606 2013/2014 : $100,000
Singh, Sheila McMaster University Identification of brain metastasis-initiating cells and regulators of brain metastasis from lung cancer	2012/2013 : $99,878 2013/2014 : $100,000
Werbowetski-Ogilvie, Tamra University of Manitoba Using human embryonic stem cells to understand early molecular events during pediatric brain tumorigenesis	2012/2013 : $94,391 2013/2014 : $85,444
Wrana, Jeffrey Mount Sinai Hospital Establishing a biological network strategy for personalizing cancer diagnosis, prognosis and drug development using genitourinary cancer as a model	2012/2013 : $99,840 2013/2014 : $99,840
Zheng, Gang Ontario Cancer Institute/PMH Photodynamic molecular beacons: improving the quality of life for spinal metastases patients	2012/2013 : $99,465 2013/2014 : $99,534

Last modified on: 16 February 2012